Browsing Sağlık Bilimleri Enstitüsü by Subject "Caco2"
Now showing items 1-1 of 1
-
The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib
(Taylor & Francis LTD, 2017)Proteasome inhibition has recently emerged as a clinically effective anticancer therapeutic approach. The first proteasome inhibitor, bortezomib (Velcade, PS-341), and new proteasome inhibitors including ixazomib have ...